Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah R Helman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The American Journal of Surgical Pathology|March 10, 2026
Comprehensive Assessment of CD19 Immunohistochemical Staining in Classic Hodgkin LymphomaSarah R Helman, Fikru Merechi, Hanan Alharthy, et al.
JAMA Network Open|January 16, 2019
Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial DesignSarah R Helman, Sanja Stevanovic, Tracy E Campbell, et al.
Plos Pathogens|October 28, 2015
Systematic Identification of Cyclic-di-GMP Binding Proteins in Vibrio cholerae Reveals a Novel Class of Cyclic-di-GMP-Binding ATPases Associated with Type II Secretion SystemsKevin G Roelofs, Christopher J Jones, Sarah R Helman, et al.
Journal for Immunotherapy of Cancer|August 29, 2019
Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1Bridget Marcinkowski, Sanja Stevanović, Sarah R Helman, et al.
Science (New York, N.Y.)|April 15, 2017
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancerSanja Stevanović, Anna Pasetto, Sarah R Helman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2018
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial CancersSanja Stevanović, Sarah R Helman, John R Wunderlich, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The American Journal of Surgical Pathology|March 10, 2026
Comprehensive Assessment of CD19 Immunohistochemical Staining in Classic Hodgkin LymphomaSarah R Helman, Fikru Merechi, Hanan Alharthy, et al.
JAMA Network Open|January 16, 2019
Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial DesignSarah R Helman, Sanja Stevanovic, Tracy E Campbell, et al.
Plos Pathogens|October 28, 2015
Systematic Identification of Cyclic-di-GMP Binding Proteins in Vibrio cholerae Reveals a Novel Class of Cyclic-di-GMP-Binding ATPases Associated with Type II Secretion SystemsKevin G Roelofs, Christopher J Jones, Sarah R Helman, et al.
Journal for Immunotherapy of Cancer|August 29, 2019
Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1Bridget Marcinkowski, Sanja Stevanović, Sarah R Helman, et al.
Science (New York, N.Y.)|April 15, 2017
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancerSanja Stevanović, Anna Pasetto, Sarah R Helman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2018
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial CancersSanja Stevanović, Sarah R Helman, John R Wunderlich, et al.
Pageof 1